In the CY 2024 OPPS/ASC final rule with comment period (88 FR 82083, 82097, 82184), we indicated we understand that hospitals establish payer-specific negotiated charges in many ways, ranging from basic fee schedules (in which dollar amounts for specific items and services are known) to grouper methodologies (in which a base rate in dollars has been established but may then be modified depending on other factors like transfers or outliers), to percent of billed charges schemes (in which the dollar amount varies from person to person and is not known until the services are performed)
I did a blog post on preloading a few months ago
,
Among the products developed in-house, Zydus, Alkem, and Sun Pharma have received approvals for both Type 2 diabetes and obesity indications, expanding their addressable market
The chart is based on dose timing and known pharmacokinetics, not a blood test, but it can help you connect side effects, hunger, and energy changes to where you are in your dosing cycle